Evidence map›Paper›PMID 40103640›Full record

ReviewDigital health

Transforming healthcare with chatbots: Uses and applications-A scoping review.

Marina Barreda, David Cantarero-Prieto, Daniel Coca, Abraham Delgado, Paloma Lanza-León, Javier Lera, Rocío Montalbán, Flora Pérez

Abstract readReview
In one paragraph

Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Artificial Intelligence in Medicine: A Definition of Terms.Journal of community hospital internal medicine perspectives · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marina BarredaResearch Group of Health Economics, IDIVAL, Santander, Cantabria, Spain.ORCID https://orcid.org/0000-0002-5952-6758
David Cantarero-PrietoResearch Group of Health Economics, IDIVAL, Santander, Cantabria, Spain.
Daniel CocaResearch Group of Health Economics, IDIVAL, Santander, Cantabria, Spain.
Abraham DelgadoHealth Department, Cantabria Government, Santander, Cantabria, Spain.ORCID https://orcid.org/0000-0002-7665-8605
Paloma Lanza-LeónResearch Group of Health Economics, IDIVAL, Santander, Cantabria, Spain.
Javier LeraResearch Group of Health Economics, IDIVAL, Santander, Cantabria, Spain.ORCID https://orcid.org/0000-0002-0367-265X
Rocío MontalbánHealth Department, Cantabria Government, Santander, Cantabria, Spain.
Flora PérezHealth Department, Cantabria Government, Santander, Cantabria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The COVID-19 pandemic has intensified the demand and use of healthcare resources, prompting the search for efficient solutions under budgetary constraints. In this context, the increasing use of artificial intelligence and telemedicine has emerged as a key strategy to optimize healthcare delivery and resources. Consequently, chatbots have emerged as innovative tools in various healthcare fields, such as mental health and patient monitoring, offering therapeutic conversations and early interventions. This systematic review aims to explore the current state of chatbots in the healthcare sector, meticulously evaluating their effectiveness, practical applications, and potential benefits. Methods: This systematic review was conducted following PRISMA guidelines, utilizing three databases, including PubMed, Web of Science, and Scopus, to identify relevant studies on the use and cost of chatbots in health over the past 5 years. Results: Several articles were identified through the database search ( Conclusion: Furthermore, there are challenges regarding the implementation of chatbots, compatibility with other systems, and ethical considerations that may arise in different healthcare settings. Addressing these issues will be essential to maximize the benefits of chatbots, mitigate risks, and ensure equitable access to these health innovations.

Indexed as

Artificial intelligencechatbotscosthealthcarepatient engagement

Identifiers

PMID40103640
PMCPMC11915287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.